Position in CLYM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,306,979
+$3,430,838 QoQ
Shares Held
330,290
+158.2% QoQ
Ownership
0.575%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 108 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in CLYM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. CLYM ranks #175 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in CLYM
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,306,979 | 330,290 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $876,141 | 127,904 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $498,680 | 124,670 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $252,099 | 125,423 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $175,364 | 141,424 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $367,080 | 300,886 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $564,907 | 313,838 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,489,388 | 292,611 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $324,763 | 45,677 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $119,101 | 43,468 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $131,521 | 48,712 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $29,408 | 11,182 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $31,309 | 11,182 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $32,616 | 11,247 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $42,182 | 11,494 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $37,125 | 11,494 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $34,711 | 11,494 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $466,324 | 55,581 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $641,145 | 61,295 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,115,406 | 62,036 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||